Literature DB >> 6638055

Pyridoxine deficiency and peripheral neuropathy associated with long-term phenelzine therapy.

C A Heller, P A Friedman.   

Abstract

A 51-year-old, nonalcoholic, nondiabetic woman with sensorimotor peripheral neuropathy and pyridoxine deficiency associated with long-term phenelzine therapy is described. Since phenelzine, like hydralazine and isoniazid, is a hydrazine capable of reducing pyridoxine levels in the rat, it is suggested that phenelzine, like hydralazine and isoniazid, may cause a pyridoxine-responsive peripheral neuropathy in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6638055     DOI: 10.1016/0002-9343(83)90422-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Phenelzine reduces plasma vitamin B6.

Authors:  D E Malcolm; P H Yu; R C Bowen; C O'Donovan; J Hawkes; M Hussein
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

Review 2.  Nutritional neuropathies.

Authors:  Nancy Hammond; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

3.  Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study.

Authors:  Kasra Amirdelfan; Jason E Pope; Joshua Gunn; Melissa M Hill; Bradley M Cotten; John E Beresh; Douglas Dobecki; Nathan Miller; Pankaj Mehta; George Girardi; Timothy R Deer
Journal:  Pain Ther       Date:  2020-06-03

Review 4.  How Well Do Current Laboratory Biomarkers Inform Clinical Decision-Making in Chronic Pain Management?

Authors:  Jonathan M Hagedorn; Joshua Gunn; Ryan Budwany; Ryan S D'Souza; Krishnan Chakravarthy; Timothy R Deer
Journal:  J Pain Res       Date:  2021-12-03       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.